What side effects may occur with Pralsetinib?

Pralsetinib is indicated for the treatment of adult patients with specific types of non-small cell lung cancer (NSCLC) that has metastasized to other parts of the body.

What side effects may occur with Pralsetinib?

The following are the most common side effects of Gavreto, including muscle and joint pain, constipation, hypertension, diarrhea, fatigue, fluid retention, fever, cough, as well as decreased levels of white blood cells, red blood cells and platelets, changes in liver function test results and liver injury, and alterations in electrolyte (including calcium and potassium) levels. If you experience any side effects that bother you, please inform your healthcare provider. Please note that Gavreto may have other side effects not listed here. If you think you are experiencing side effects from the medication, contact your healthcare provider.

Indications of Pralsetinib

Pralsetinib is also indicated for the treatment of specific types of thyroid cancer that has progressed or metastasized to other parts of the body, in pediatric patients aged 12 years and older and adult patients. In addition, Pralsetinib is indicated for the treatment of specific types of thyroid cancer that has progressed or metastasized to other parts of the body and is refractory to radioactive iodine therapy, in pediatric patients aged 12 years and older and adult patients. Pralsetinib is a member of the kinase inhibitor class of medications. It exerts its therapeutic effect by blocking the activity of a certain natural substance that may promote cancer cell proliferation.

Dosage and Administration of Pralsetinib

Pralsetinib is available as oral capsules. It is usually administered once daily on an empty stomach, at least 2 hours before or 1 hour after a meal. Pralsetinib should be taken at approximately the same time each day. Follow the instructions on the prescription label carefully, and consult your doctor or pharmacist if you have any questions. Take Pralsetinib exactly as directed. Do not increase or decrease the dose without authorization, nor take it more frequently than prescribed by your doctor.

If vomiting occurs after taking a dose, do not take an extra dose. Resume dosing according to the regular schedule.

If certain side effects occur, your doctor may reduce your dose or temporarily or permanently discontinue treatment. It is important to inform your doctor about how you feel during treatment with Pralsetinib.